SidaGhanaV1, Ncbi, Merge, bibRecord, 000A13

HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.

Identifieur interne : 000A13 ( Ncbi/Merge ); précédent : 000A12; suivant : 000A14

HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.

Auteurs : Tegwinde Rebeca Compaore [Burkina Faso] ; Birama Diarra [Burkina Faso] ; Maleki Assih [Burkina Faso] ; Dorcas Obiri-Yeboah [Ghana] ; Serge Theophile Soubeiga [Burkina Faso] ; Abdoul Karim Ouattara [Burkina Faso] ; Damehan Tchelougou [Burkina Faso] ; Cyrille Bisseye [Burkina Faso] ; Didier Romuald Bakouan [Burkina Faso] ; Issaka Pierre Compaore [Burkina Faso] ; Augustine Dembele [Burkina Faso] ; Wendkuuni Florencia Djigma [Burkina Faso] ; Jacques Simpore [Burkina Faso]

Source :

BMC infectious diseases [ 1471-2334 ] ; 2016.

RBID : pubmed:27449138

Descripteurs français

KwdFr :
- APOBEC-3G Deaminase (génétique), Adulte, Allèles, Burkina (épidémiologie), Co-infection (génétique), Co-infection (épidémiologie), Femelle, Fréquence d'allèle, Génotype, Haplotypes, Humains, Hépatite B (génétique), Hépatite B (épidémiologie), Infections à VIH (génétique), Infections à VIH (épidémiologie), Mâle, Polymorphisme de nucléotide simple, Prédisposition génétique à une maladie, Prévalence, VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (pathogénicité), Virus de l'hépatite B (pathogénicité), Études cas-témoins, Études d'associations génétiques.
MESH :
- génétique : APOBEC-3G Deaminase, Co-infection, Hépatite B, Infections à VIH.
- pathogénicité : VIH-1 (Virus de l'Immunodéficience Humaine de type 1), Virus de l'hépatite B.
- épidémiologie : Burkina, Co-infection, Hépatite B, Infections à VIH.
- Adulte, Allèles, Femelle, Fréquence d'allèle, Génotype, Haplotypes, Humains, Mâle, Polymorphisme de nucléotide simple, Prédisposition génétique à une maladie, Prévalence, Études cas-témoins, Études d'associations génétiques.

English descriptors

KwdEn :
- APOBEC-3G Deaminase (genetics), Adult, Alleles, Burkina Faso (epidemiology), Case-Control Studies, Coinfection (epidemiology), Coinfection (genetics), Female, Gene Frequency, Genetic Association Studies, Genetic Predisposition to Disease, Genotype, HIV Infections (epidemiology), HIV Infections (genetics), HIV-1 (pathogenicity), Haplotypes, Hepatitis B (epidemiology), Hepatitis B (genetics), Hepatitis B virus (pathogenicity), Humans, Male, Polymorphism, Single Nucleotide, Prevalence.
MESH :
- chemical , genetics : APOBEC-3G Deaminase.
- epidemiology : Burkina Faso, Coinfection, HIV Infections, Hepatitis B.
- genetics : Coinfection, HIV Infections, Hepatitis B.
- pathogenicity : HIV-1, Hepatitis B virus.
- Adult, Alleles, Case-Control Studies, Female, Gene Frequency, Genetic Association Studies, Genetic Predisposition to Disease, Genotype, Haplotypes, Humans, Male, Polymorphism, Single Nucleotide, Prevalence.

Abstract

Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G (APOBEC3G) is a potent host defense factor, which interferes with HIV-1 and HBV. Our study had three objectives, to screen a population of HIV-1 infected and uninfected patients in Burkina Faso for HBV, to screen the population for APOBEC3G variants rs6001417, rs8177832, and rs35228531 previously described, and to analyze the effect of these three variants and their haplotypes on HIV-1/HBV co-infection in Burkina Faso.

DOI: 10.1186/s12879-016-1672-2
PubMed: 27449138

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000500
to stream PubMed, to step Curation: 000500
to stream PubMed, to step Checkpoint: 000500

Links to Exploration step

pubmed:27449138

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.</title>
<author><name sortKey="Compaore, Tegwinde Rebeca" sort="Compaore, Tegwinde Rebeca" uniqKey="Compaore T" first="Tegwinde Rebeca" last="Compaore">Tegwinde Rebeca Compaore</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Diarra, Birama" sort="Diarra, Birama" uniqKey="Diarra B" first="Birama" last="Diarra">Birama Diarra</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Assih, Maleki" sort="Assih, Maleki" uniqKey="Assih M" first="Maleki" last="Assih">Maleki Assih</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Obiri Yeboah, Dorcas" sort="Obiri Yeboah, Dorcas" uniqKey="Obiri Yeboah D" first="Dorcas" last="Obiri-Yeboah">Dorcas Obiri-Yeboah</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Department of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Cape Coast</wicri:regionArea>
<wicri:noRegion>Cape Coast</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Soubeiga, Serge Theophile" sort="Soubeiga, Serge Theophile" uniqKey="Soubeiga S" first="Serge Theophile" last="Soubeiga">Serge Theophile Soubeiga</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ouattara, Abdoul Karim" sort="Ouattara, Abdoul Karim" uniqKey="Ouattara A" first="Abdoul Karim" last="Ouattara">Abdoul Karim Ouattara</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tchelougou, Damehan" sort="Tchelougou, Damehan" uniqKey="Tchelougou D" first="Damehan" last="Tchelougou">Damehan Tchelougou</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bisseye, Cyrille" sort="Bisseye, Cyrille" uniqKey="Bisseye C" first="Cyrille" last="Bisseye">Cyrille Bisseye</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bakouan, Didier Romuald" sort="Bakouan, Didier Romuald" uniqKey="Bakouan D" first="Didier Romuald" last="Bakouan">Didier Romuald Bakouan</name>
<affiliation wicri:level="1"><nlm:affiliation>Permanent Secretary against Aids and sexually transmitted diseases, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Permanent Secretary against Aids and sexually transmitted diseases, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Compaore, Issaka Pierre" sort="Compaore, Issaka Pierre" uniqKey="Compaore I" first="Issaka Pierre" last="Compaore">Issaka Pierre Compaore</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dembele, Augustine" sort="Dembele, Augustine" uniqKey="Dembele A" first="Augustine" last="Dembele">Augustine Dembele</name>
<affiliation wicri:level="1"><nlm:affiliation>Permanent Secretary against Aids and sexually transmitted diseases, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Permanent Secretary against Aids and sexually transmitted diseases, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Djigma, Wendkuuni Florencia" sort="Djigma, Wendkuuni Florencia" uniqKey="Djigma W" first="Wendkuuni Florencia" last="Djigma">Wendkuuni Florencia Djigma</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Simpore, Jacques" sort="Simpore, Jacques" uniqKey="Simpore J" first="Jacques" last="Simpore">Jacques Simpore</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso. jacques.simpore@yahoo.fr.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27449138</idno>
<idno type="pmid">27449138</idno>
<idno type="doi">10.1186/s12879-016-1672-2</idno>
<idno type="wicri:Area/PubMed/Corpus">000500</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000500</idno>
<idno type="wicri:Area/PubMed/Curation">000500</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000500</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000500</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000500</idno>
<idno type="wicri:Area/Ncbi/Merge">000A13</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.</title>
<author><name sortKey="Compaore, Tegwinde Rebeca" sort="Compaore, Tegwinde Rebeca" uniqKey="Compaore T" first="Tegwinde Rebeca" last="Compaore">Tegwinde Rebeca Compaore</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Diarra, Birama" sort="Diarra, Birama" uniqKey="Diarra B" first="Birama" last="Diarra">Birama Diarra</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Assih, Maleki" sort="Assih, Maleki" uniqKey="Assih M" first="Maleki" last="Assih">Maleki Assih</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Obiri Yeboah, Dorcas" sort="Obiri Yeboah, Dorcas" uniqKey="Obiri Yeboah D" first="Dorcas" last="Obiri-Yeboah">Dorcas Obiri-Yeboah</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana.</nlm:affiliation>
<country xml:lang="fr">Ghana</country>
<wicri:regionArea>Department of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Cape Coast</wicri:regionArea>
<wicri:noRegion>Cape Coast</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Soubeiga, Serge Theophile" sort="Soubeiga, Serge Theophile" uniqKey="Soubeiga S" first="Serge Theophile" last="Soubeiga">Serge Theophile Soubeiga</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ouattara, Abdoul Karim" sort="Ouattara, Abdoul Karim" uniqKey="Ouattara A" first="Abdoul Karim" last="Ouattara">Abdoul Karim Ouattara</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tchelougou, Damehan" sort="Tchelougou, Damehan" uniqKey="Tchelougou D" first="Damehan" last="Tchelougou">Damehan Tchelougou</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bisseye, Cyrille" sort="Bisseye, Cyrille" uniqKey="Bisseye C" first="Cyrille" last="Bisseye">Cyrille Bisseye</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bakouan, Didier Romuald" sort="Bakouan, Didier Romuald" uniqKey="Bakouan D" first="Didier Romuald" last="Bakouan">Didier Romuald Bakouan</name>
<affiliation wicri:level="1"><nlm:affiliation>Permanent Secretary against Aids and sexually transmitted diseases, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Permanent Secretary against Aids and sexually transmitted diseases, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Compaore, Issaka Pierre" sort="Compaore, Issaka Pierre" uniqKey="Compaore I" first="Issaka Pierre" last="Compaore">Issaka Pierre Compaore</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dembele, Augustine" sort="Dembele, Augustine" uniqKey="Dembele A" first="Augustine" last="Dembele">Augustine Dembele</name>
<affiliation wicri:level="1"><nlm:affiliation>Permanent Secretary against Aids and sexually transmitted diseases, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Permanent Secretary against Aids and sexually transmitted diseases, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Djigma, Wendkuuni Florencia" sort="Djigma, Wendkuuni Florencia" uniqKey="Djigma W" first="Wendkuuni Florencia" last="Djigma">Wendkuuni Florencia Djigma</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Simpore, Jacques" sort="Simpore, Jacques" uniqKey="Simpore J" first="Jacques" last="Simpore">Jacques Simpore</name>
<affiliation wicri:level="1"><nlm:affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso. jacques.simpore@yahoo.fr.</nlm:affiliation>
<country xml:lang="fr">Burkina Faso</country>
<wicri:regionArea>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou</wicri:regionArea>
<wicri:noRegion>Ouagadougou</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">BMC infectious diseases</title>
<idno type="eISSN">1471-2334</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>APOBEC-3G Deaminase (genetics)</term>
<term>Adult</term>
<term>Alleles</term>
<term>Burkina Faso (epidemiology)</term>
<term>Case-Control Studies</term>
<term>Coinfection (epidemiology)</term>
<term>Coinfection (genetics)</term>
<term>Female</term>
<term>Gene Frequency</term>
<term>Genetic Association Studies</term>
<term>Genetic Predisposition to Disease</term>
<term>Genotype</term>
<term>HIV Infections (epidemiology)</term>
<term>HIV Infections (genetics)</term>
<term>HIV-1 (pathogenicity)</term>
<term>Haplotypes</term>
<term>Hepatitis B (epidemiology)</term>
<term>Hepatitis B (genetics)</term>
<term>Hepatitis B virus (pathogenicity)</term>
<term>Humans</term>
<term>Male</term>
<term>Polymorphism, Single Nucleotide</term>
<term>Prevalence</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>APOBEC-3G Deaminase (génétique)</term>
<term>Adulte</term>
<term>Allèles</term>
<term>Burkina (épidémiologie)</term>
<term>Co-infection (génétique)</term>
<term>Co-infection (épidémiologie)</term>
<term>Femelle</term>
<term>Fréquence d'allèle</term>
<term>Génotype</term>
<term>Haplotypes</term>
<term>Humains</term>
<term>Hépatite B (génétique)</term>
<term>Hépatite B (épidémiologie)</term>
<term>Infections à VIH (génétique)</term>
<term>Infections à VIH (épidémiologie)</term>
<term>Mâle</term>
<term>Polymorphisme de nucléotide simple</term>
<term>Prédisposition génétique à une maladie</term>
<term>Prévalence</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (pathogénicité)</term>
<term>Virus de l'hépatite B (pathogénicité)</term>
<term>Études cas-témoins</term>
<term>Études d'associations génétiques</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>APOBEC-3G Deaminase</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Burkina Faso</term>
<term>Coinfection</term>
<term>HIV Infections</term>
<term>Hepatitis B</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Coinfection</term>
<term>HIV Infections</term>
<term>Hepatitis B</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>APOBEC-3G Deaminase</term>
<term>Co-infection</term>
<term>Hépatite B</term>
<term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>HIV-1</term>
<term>Hepatitis B virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
<term>Virus de l'hépatite B</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Burkina</term>
<term>Co-infection</term>
<term>Hépatite B</term>
<term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Alleles</term>
<term>Case-Control Studies</term>
<term>Female</term>
<term>Gene Frequency</term>
<term>Genetic Association Studies</term>
<term>Genetic Predisposition to Disease</term>
<term>Genotype</term>
<term>Haplotypes</term>
<term>Humans</term>
<term>Male</term>
<term>Polymorphism, Single Nucleotide</term>
<term>Prevalence</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Allèles</term>
<term>Femelle</term>
<term>Fréquence d'allèle</term>
<term>Génotype</term>
<term>Haplotypes</term>
<term>Humains</term>
<term>Mâle</term>
<term>Polymorphisme de nucléotide simple</term>
<term>Prédisposition génétique à une maladie</term>
<term>Prévalence</term>
<term>Études cas-témoins</term>
<term>Études d'associations génétiques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G (APOBEC3G) is a potent host defense factor, which interferes with HIV-1 and HBV. Our study had three objectives, to screen a population of HIV-1 infected and uninfected patients in Burkina Faso for HBV, to screen the population for APOBEC3G variants rs6001417, rs8177832, and rs35228531 previously described, and to analyze the effect of these three variants and their haplotypes on HIV-1/HBV co-infection in Burkina Faso.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27449138</PMID>
<DateCreated><Year>2016</Year>
<Month>07</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>07</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>07</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>16</Volume>
<PubDate><Year>2016</Year>
<Month>Jul</Month>
<Day>22</Day>
</PubDate>
</JournalIssue>
<Title>BMC infectious diseases</Title>
<ISOAbbreviation>BMC Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.</ArticleTitle>
<Pagination><MedlinePgn>336</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-016-1672-2</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G (APOBEC3G) is a potent host defense factor, which interferes with HIV-1 and HBV. Our study had three objectives, to screen a population of HIV-1 infected and uninfected patients in Burkina Faso for HBV, to screen the population for APOBEC3G variants rs6001417, rs8177832, and rs35228531 previously described, and to analyze the effect of these three variants and their haplotypes on HIV-1/HBV co-infection in Burkina Faso.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">HBV detection was performed on samples from HIV-1 infected and uninfected subjects using rapid detection tests and real-time PCR. APOBEC3 genotyping was done by the TaqMan allelic discrimination method. Fisher Exact test, Odds ratio (OR), confidence intervals (CI) at 95 %, Linkage disequilibrium (LD) summary statistics and haplotype frequencies were calculated.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalence of HBV was 56.7 % among HIV-1 positive patients of our study while it was about 12.8 % among HIV-1 seronegative subjects. Genotype E was the genotype of HBV present in our hepatitis B positive samples. Minor allele frequencies of rs6001417, rs8177832, and rs35228531 were higher in seronegative subjects. The T minor allele of variant rs35228531 was protective against HIV-1/HBV co-infection with OR = 0.61, 95 % CI (0.42-0.90), p = 0.013. There was also an association between the GGT haplotype and protection against HIV-1/HBV co-infection, OR = 0.57, 95 % CI (0.33-0.99), p = 0.050. The other haplotypes present in the population were not statistically significant. There minor allele T of the rs35228531 was protective against HIV mono-infection OR = 0.53, 95 % CI (0.3-0.93), P = 0.030. But there was no effect of protection against HBV mono-infection.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">APOBEC3G through its variants rs6001417, rs8177832, and rs35228531, in this study interferes with HIV-1/HBV co-infection could be due the HIV-1 mono-infection in a population from Burkina Faso.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Compaore</LastName>
<ForeName>Tegwinde Rebeca</ForeName>
<Initials>TR</Initials>
<AffiliationInfo><Affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Diarra</LastName>
<ForeName>Birama</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Assih</LastName>
<ForeName>Maleki</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Obiri-Yeboah</LastName>
<ForeName>Dorcas</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Soubeiga</LastName>
<ForeName>Serge Theophile</ForeName>
<Initials>ST</Initials>
<AffiliationInfo><Affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ouattara</LastName>
<ForeName>Abdoul Karim</ForeName>
<Initials>AK</Initials>
<AffiliationInfo><Affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tchelougou</LastName>
<ForeName>Damehan</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bisseye</LastName>
<ForeName>Cyrille</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bakouan</LastName>
<ForeName>Didier Romuald</ForeName>
<Initials>DR</Initials>
<AffiliationInfo><Affiliation>Permanent Secretary against Aids and sexually transmitted diseases, Ouagadougou, Burkina Faso.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Compaore</LastName>
<ForeName>Issaka Pierre</ForeName>
<Initials>IP</Initials>
<AffiliationInfo><Affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dembele</LastName>
<ForeName>Augustine</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Permanent Secretary against Aids and sexually transmitted diseases, Ouagadougou, Burkina Faso.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Djigma</LastName>
<ForeName>Wendkuuni Florencia</ForeName>
<Initials>WF</Initials>
<AffiliationInfo><Affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Simpore</LastName>
<ForeName>Jacques</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Pietro Annigoni Biomolecular Research Centre (CERBA)/LABIOGENE, University of Ouagadougou, Ouagadougou, Burkina Faso. jacques.simpore@yahoo.fr.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>07</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>BMC Infect Dis</MedlineTA>
<NlmUniqueID>100968551</NlmUniqueID>
<ISSNLinking>1471-2334</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>EC 3.5.4.5</RegistryNumber>
<NameOfSubstance UI="D000071480">APOBEC-3G Deaminase</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.5.4.5</RegistryNumber>
<NameOfSubstance UI="C464924">APOBEC3G protein, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Hepat Res Treat. 2014;2014:781843</RefSource>
<PMID Version="1">25161770</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Braz J Infect Dis. 2010 May-Jun;14(3):219-24</RefSource>
<PMID Version="1">20835503</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2006 Aug 1;22(15):1928-9</RefSource>
<PMID Version="1">16720584</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Viral Hepat. 2013 Oct;20(10 ):678-86</RefSource>
<PMID Version="1">24010642</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 1988 Feb 11;16(3):1215</RefSource>
<PMID Version="1">3344216</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2007 May;81(9):4465-72</RefSource>
<PMID Version="1">17314171</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 2006 Oct 3;20(15):1984-6</RefSource>
<PMID Version="1">16988524</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Science. 2002 Jun 21;296(5576):2225-9</RefSource>
<PMID Version="1">12029063</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Clin Exp Med. 2015 May 15;8(5):7762-9</RefSource>
<PMID Version="1">26221327</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2007 Jun;7(6):402-9</RefSource>
<PMID Version="1">17521593</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Hepatol. 2006;44(1 Suppl):S6-9</RefSource>
<PMID Version="1">16352363</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2003 Jan;10 Suppl 1:S25-6</RefSource>
<PMID Version="1">12655343</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2005 Jan 15;191(2):159-63</RefSource>
<PMID Version="1">15609224</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2004 Oct;78(20):11070-6</RefSource>
<PMID Version="1">15452227</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood Transfus. 2011 Oct;9(4):419-24</RefSource>
<PMID Version="1">21839011</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 2010 Jan 16;24(2):195-204</RefSource>
<PMID Version="1">19996938</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Virol. 2007 Mar;38(3):238-43</RefSource>
<PMID Version="1">17224304</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2005 Jun 7;102(23 ):8321-6</RefSource>
<PMID Version="1">15919829</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2008 Feb 1;46(3):367-9</RefSource>
<PMID Version="1">18171305</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Infect Dis. 2014 Dec;29:125-32</RefSource>
<PMID Version="1">25449246</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Jan 07;11(1):e0146386</RefSource>
<PMID Version="1">26741797</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Liver Int. 2005 Apr;25(2):201-13</RefSource>
<PMID Version="1">15780040</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2005 May 1;21(9):2128-9</RefSource>
<PMID Version="1">15705655</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Med Sci. 2006;3(2):57-62</RefSource>
<PMID Version="1">16614744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2005 Aug;42(2):301-9</RefSource>
<PMID Version="1">16025511</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2012 Oct;12(10):687-95</RefSource>
<PMID Version="1">22976433</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Infect Dis. 2016 Jan 13;16:14</RefSource>
<PMID Version="1">26759172</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hepatol Res. 2007 Jul;37(s1):S9-S19</RefSource>
<PMID Version="1">17627641</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S274-85</RefSource>
<PMID Version="1">25768867</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2005 Mar;41(3):626-33</RefSource>
<PMID Version="1">15726649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Annu Rev Immunol. 2008;26:317-53</RefSource>
<PMID Version="1">18304004</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Exp Clin Cancer Res. 2015 Jul 25;34:70</RefSource>
<PMID Version="1">26205887</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2004 Nov;4(11):868-77</RefSource>
<PMID Version="1">15516966</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000071480" MajorTopicYN="N">APOBEC-3G Deaminase</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002050" MajorTopicYN="N">Burkina Faso</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4957463</OtherID>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">APOBEC3G variants</Keyword>
<Keyword MajorTopicYN="N">Burkina Faso</Keyword>
<Keyword MajorTopicYN="N">HIV-1/HBV co-infection</Keyword>
<Keyword MajorTopicYN="N">Real time PCR</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>02</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>06</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>7</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>7</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27449138</ArticleId>
<ArticleId IdType="doi">10.1186/s12879-016-1672-2</ArticleId>
<ArticleId IdType="pii">10.1186/s12879-016-1672-2</ArticleId>
<ArticleId IdType="pmc">PMC4957463</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Burkina Faso</li>
<li>Ghana</li>
</country>
</list>
<tree><country name="Burkina Faso"><noRegion><name sortKey="Compaore, Tegwinde Rebeca" sort="Compaore, Tegwinde Rebeca" uniqKey="Compaore T" first="Tegwinde Rebeca" last="Compaore">Tegwinde Rebeca Compaore</name>
</noRegion>
<name sortKey="Assih, Maleki" sort="Assih, Maleki" uniqKey="Assih M" first="Maleki" last="Assih">Maleki Assih</name>
<name sortKey="Bakouan, Didier Romuald" sort="Bakouan, Didier Romuald" uniqKey="Bakouan D" first="Didier Romuald" last="Bakouan">Didier Romuald Bakouan</name>
<name sortKey="Bisseye, Cyrille" sort="Bisseye, Cyrille" uniqKey="Bisseye C" first="Cyrille" last="Bisseye">Cyrille Bisseye</name>
<name sortKey="Compaore, Issaka Pierre" sort="Compaore, Issaka Pierre" uniqKey="Compaore I" first="Issaka Pierre" last="Compaore">Issaka Pierre Compaore</name>
<name sortKey="Dembele, Augustine" sort="Dembele, Augustine" uniqKey="Dembele A" first="Augustine" last="Dembele">Augustine Dembele</name>
<name sortKey="Diarra, Birama" sort="Diarra, Birama" uniqKey="Diarra B" first="Birama" last="Diarra">Birama Diarra</name>
<name sortKey="Djigma, Wendkuuni Florencia" sort="Djigma, Wendkuuni Florencia" uniqKey="Djigma W" first="Wendkuuni Florencia" last="Djigma">Wendkuuni Florencia Djigma</name>
<name sortKey="Ouattara, Abdoul Karim" sort="Ouattara, Abdoul Karim" uniqKey="Ouattara A" first="Abdoul Karim" last="Ouattara">Abdoul Karim Ouattara</name>
<name sortKey="Simpore, Jacques" sort="Simpore, Jacques" uniqKey="Simpore J" first="Jacques" last="Simpore">Jacques Simpore</name>
<name sortKey="Soubeiga, Serge Theophile" sort="Soubeiga, Serge Theophile" uniqKey="Soubeiga S" first="Serge Theophile" last="Soubeiga">Serge Theophile Soubeiga</name>
<name sortKey="Tchelougou, Damehan" sort="Tchelougou, Damehan" uniqKey="Tchelougou D" first="Damehan" last="Tchelougou">Damehan Tchelougou</name>
</country>
<country name="Ghana"><noRegion><name sortKey="Obiri Yeboah, Dorcas" sort="Obiri Yeboah, Dorcas" uniqKey="Obiri Yeboah D" first="Dorcas" last="Obiri-Yeboah">Dorcas Obiri-Yeboah</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A13 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000A13 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:27449138
   |texte=   HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:27449138" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaGhanaV1

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024

	Le SIDA au Ghana (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Le SIDA au Ghana (serveur d'exploration)

HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.

HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki